Given that the NLRP3 inflammasome contributes to hepatocyte lipid metabolism disorders 27, we next examined whether inhibiting NLRP3 with Cas9/gNLRP3@M-N could attenuate hepatic steatosis in GAN diet-fed mice. This evidence concerns the gene NLRP3 and fatty liver disease.